A validated LC-MS/MS method for simultaneous quantitation of piperacillin, cefazolin, and cefoxitin in rat plasma and twelve tissues
Yi-Hua Sheng,Anna Siemiątkowska,Katarzyna Kosicka-Noworzyń,Luigi Brunetti,Leonid Kagan
DOI: https://doi.org/10.1016/j.jpba.2024.116259
IF: 3.571
2024-06-04
Journal of Pharmaceutical and Biomedical Analysis
Abstract:Background The investigation of drug disposition in tissues is critical to improving dosing strategy and maximizing treatment effectiveness, yet developing a multi-tissue bioanalytical method could be challenging due to the differences among various matrices. Herein, we developed an LC-MS/MS method tailored for the quantitation of piperacillin (PIP), cefazolin (CFZ), and cefoxitin (CFX) in rat plasma and 12 tissues, accompanied by validation data for each matrix according to the FDA and EMA guidelines. Results The method required only a small sample volume (5 μL plasma or 50 - 100 μL tissue homogenates) and a relatively simple protocol for the simultaneous quantitation of the PIP, CFZ, and CFX within different biological matrices. Mobile phase A was composed of 5 mM ammonium formate and 0.1% formic acid in water, while mobile phase B contained 0.1% FA in ACN. The mobile phase was pumped through a Synergi Fusion-RP column equipped with a guard column with a gradient elution program at a 0.3 mL/min flow rate. The mass spectrometer was operated in positive ionization mode (ESI+) using multiple reaction monitoring modes. Significance The validated method has been successfully applied to quantify PIP, CFZ, and CFX from the plasma and tissue samples collected in a pilot study and will further be used in a large pharmacokinetics study. To our knowledge, this is also the first report presenting long-term, freeze-thaw, and autosampler stability data for PIP, CFZ, and CFX prepared in rat plasma and multiple tissues.
pharmacology & pharmacy,chemistry, analytical